Avista Healthcare

BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ — Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it has purchased G&W Laboratories’ finished dosage manufacturing plant located in Lincolnton, NC. “The purchase of the Lincolnton plant expands Cosette’s capabilities into new dosage forms while simultaneously allowing us to enter a new business […]

Zurich, 15 October 2019 – Acino and Takeda Pharmaceuticals announced today that they have signed an agreement for Acino to acquire parts of Takeda’s primary care portfolio in selected countries in the Middle East and Africa, and in Ukraine. The acquisition will further strengthen Acino’s position in these important regions. Acino will acquire approximately 30 […]

NEW YORK, Oct. 8, 2019 /PRNewswire/ — Kramer Laboratories, Inc., a healthcare company that delivers innovative products to help consumers self-treat their everyday problems, announced today that it has changed its corporate name to Arcadia Consumer Healthcare, Inc. “Kramer Laboratories began as a small, family-owned company out of Florida over 35 years ago, and we couldn’t be prouder of our […]

NEW YORK and CHICAGO, Sept. 3, 2019 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, and May River Capital, LLC (“May River”), an investor in lower middle-market industrial growth businesses, today announced that Avista has acquired GCM Holding Corporation (“GCM” or the “Company”) from May River. Based in Silicon Valley, GCM is […]

NEW YORK and STOCKHOLM, June 25, 2019 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, announced the signing of a definitive agreement whereby Karo Pharma AB (publ) (“Karo Pharma”), a specialty pharma company, will acquire Trimb Healthcare (“Trimb”) for SEK 3.4 billion. The transaction is subject to customary competition authority review […]

May 6, 2019 at 4:30 PM EDT –Second Phase III Study 202 Meets Primary Endpoint; Provides Additional Evidence of Efficacy and Safety – – Long-term Phase III Study 203 Provides Additional Evidence of Safety – – Company to Host Conference Call on Tuesday, May 7th at 12pm ET with Dr. Chuck Slonim and Dr. Shane Kannarr – BRIDGEWATER, N.J., May 06, 2019 (GLOBE NEWSWIRE) — Osmotica […]

Canton, MA, March 4, 2019 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that a new case series published in Plastic and Reconstructive Surgery – Global Open suggests PuraPly® Antimicrobial (PuraPly AM) positively […]

STOCKHOLM, Feb. 21, 2019 /PRNewswire/ — Trimb Healthcare AB (“Trimb”) has entered into an exclusive licensing agreement with Teva in Scandinavia for a portfolio of established OTC brands. The products include Flux, a market-leading brand in fluoride rinse, Decubal, a leading skincare brand for dry and sensitive skin, and other well-known OTC brands such as Fludent, Apobase, […]

Canton, MA and New York, NY, December 10, 2018 – Organogenesis Holdings Inc. (“ORGO”), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, today announced the completion of its previously announced business combination between Organogenesis Inc. and Avista Healthcare […]

Stockholm, December 7, 2018 – Trimb Healthcare (“Trimb”) has completed the acquisition of BioClin BV (“BioClin”), a leading intimate healthcare company based in Delft, Netherlands.  The BioClin portfolio includes several well-known, all-natural brands, such as Multi-Gyn, a leading intimate product line treating vaginal discomforts, and Multi-Mam, an innovative product line for breastfeeding mothers. BioClin’s brands […]

11/06/2018 – 17:25 Trimb Healthcare AB (“Trimb”) has entered into a definitive agreement with CCS Healthcare Nordic AB (“CCS”) to acquire their portfolio of skin care products in Sweden, Norway and the UK (“CCS Skincare Brands”). The portfolio includes several well-established and highly recognized brands, including CCS Swedish Formula, Indy Beauty1, Oliva, Bamse2, and exclusive […]

NEW YORK, Nov. 6, 2018 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, and G&W Laboratories, Inc. (“G&W Labs”), today announced the signing of a definitive agreement for Avista to acquire G&W Labs’ extended topicals and dermatology business unit (“G&W Dermatology” or the “Company”). The transaction does not involve G&W […]